OvaScience will not meet goal By: MarketMinute.com Stock News September 29, 2015 at 17:50 PM EDT OvaScience Inc. (Nasdaq: OVAS) does not expect to meet its 2015 goal of 1,000 AUGMENT treatment cycles. The stock price plummeted $5.95 to close at $8.57. Related Stocks: Ovascience